2019

BENDEKA & TREANDA (EGRX, TEVA): FDA CONSIDERS NEXT STEPS IN BENDAMUSTINE EXCLUSIVITY FIGHT

Visit USCO

Text Registration

BENDEKA & TREANDA (EGRX, TEVA): FDA CONSIDERS NEXT STEPS IN BENDAMUSTINE EXCLUSIVITY FIGHT

Status

Published

on 14 Oct 2019

Year of Creation

2019

IPD Analytics LLC

Registration Number

TX0008808653

on 14 Oct 2019

The U.S. Copyright record (Registration Number: TX0008808653) dated 14 Oct 2019, pertains to an electronic file (eService) titled "BENDEKA & TREANDA (EGRX, TEVA): FDA CONSIDERS NEXT STEPS IN BENDAMUSTINE EXCLUSIVITY FIGHT" created in 2019. The copyright holder is IPD Analytics LLC, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to IPD Analytics LLC.

IPD Analytics LLC

Application Details

Registration Number

TX0008808653

Registration Date

10/14/2019

Year of Creation

2019

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

IPD Analytics LLC

Physical Description

Electronic file (eService)

First Publication Nation

United States

Corporate Authors

IPD Analytics LLC

Statements

Application Title Statement: BENDEKA & TREANDA (EGRX, TEVA): FDA CONSIDERS NEXT STEPS IN BENDAMUSTINE EXCLUSIVITY FIGHT

Author Statement: IPD Analytics LLC employer for hire Domicile: United States Citizenship: United States Authorship: text

Statements

Application Title Statement: BENDEKA & TREANDA (EGRX, TEVA): FDA CONSIDERS NEXT STEPS IN BENDAMUSTINE EXCLUSIVITY FIGHT

Author Statement: IPD Analytics LLC employer for hire Domicile: United States Citizenship: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.